Skip to main content
TipRanks
Go Ultimate75% OFF

YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) AI Stock Analysis

0 Followers
JP:9265

YAMASHITA HEALTH CARE HOLDINGS, INC.

(TSE/TYO:9265)

Select Model
Rating:50Neutral
Price Target:JPY 3,645.00â–²(6.11% Upside)
Action:reiterated
Date:11/05/26

The overall score is constrained by a sharp deterioration in cash flow, which is a significant risk despite a fortress-like balance sheet. Bearish technical momentum and near-oversold conditions add downward pressure. Positively, the stock offers a reasonable valuation and an attractive dividend yield, supported by a debt-free capital structure.

Positive Factors
Strong Revenue GrowthRevenue growth of approximately 51% demonstrates strong recent expansion in the company’s healthcare distribution and solutions activities. If sustained, this larger revenue base can improve operating scale, strengthen customer reach, and provide a platform for future earnings growth.
Negative Factors
Weak Cash GenerationThe sharp deterioration in operating cash flow and the move to negative free cash flow show that reported profitability is not currently converting reliably into cash. Persistently weak conversion could constrain investment, working-capital funding, and the company’s ability to sustain shareholder distributions.

YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%JP:9265+7.95%EWJ+11.78%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 8.43B
Dividend Yield
3.11%
Average Volume (3M)
1,852
Price to Earnings (P/E)
15.6
Beta (1Y)
0.01
Revenue Growth
-0.41%
EPS Growth
2.32%
Country
Japan
Employees
617
Sector
Healthcare
Sector Strength
51
Industry
Medical - Distribution

YAMASHITA HEALTH CARE HOLDINGS, INC. Business Overview & Revenue Model

Company Description

Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, and surgical equipment comprising electric scalpels, ort...

YAMASHITA HEALTH CARE HOLDINGS, INC. Financial Statement Overview

Summary

Financial performance is mixed. The balance sheet is excellent with zero debt and strong equity (Score 85), but cash flow has deteriorated sharply with negative free cash flow (Score 25). The income statement shows thin, stable margins and modest growth (Score 45). Overall, the robust balance sheet is offset by weak cash generation.

Income Statement

45Neutral

Balance Sheet

85Very Positive

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMMay 2025May 2024May 2023May 2022May 2021
Income Statement
Total Revenue64.15B64.15B64.49B61.55B58.20B55.15B
Gross Profit8.69B8.55B8.57B8.30B7.86B7.52B
EBITDA998.00M1.04B1.06B1.18B1.36B1.15B
Net Income648.00M648.00M616.00M580.00M218.00M696.08M
Balance Sheet
Total Assets27.09B27.09B27.55B26.56B24.83B24.39B
Cash, Cash Equivalents and Short-Term Investments4.13B4.13B5.70B5.30B5.83B3.98B
Total Debt000000
Total Liabilities17.73B17.73B18.56B18.00B16.90B16.38B
Stockholders Equity9.36B9.36B8.98B8.54B7.91B7.98B
Cash Flow
Free Cash Flow-1.20B-1.20B338.00M804.00M2.12B473.94M
Operating Cash Flow88.00M88.00M617.00M878.00M2.17B581.27M
Investing Cash Flow-1.32B-1.32B19.00M-1.07B-107.00M-27.66M
Financing Cash Flow-337.00M-337.00M-240.00M-335.00M-209.00M-230.00M

YAMASHITA HEALTH CARE HOLDINGS, INC. Technical Analysis

Technical Analysis SentimentNegative
Last Price3435.00

Price Trends

50DMA3603.60Negative
100DMA3558.95Negative
200DMA3484.82Negative

Market Momentum

MACD30.11Negative
RSI39.50Neutral
STOCH68.16Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9265, the sentiment is Negative. The current price of 3435.00 is below the 20-day moving average (MA) of 3603.00, below the 50-day MA of 3603.60, and below the 200-day MA of 3484.82, indicating a bearish trend. The MACD of 30.11 indicates Negative momentum. The RSI at 39.50 is Neutral, neither overbought nor oversold. The STOCH value of 68.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9265.

YAMASHITA HEALTH CARE HOLDINGS, INC. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:9265 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6062JP:606273OutperformJPY 64.04B14.44―2.19%5.50%45.42%
JP:2425JP:242555NeutralJPY 2.50B28.24―3.34%-3.64%-66.52%
JP:3417JP:341753NeutralJPY 13.03B17.01―3.17%2.87%-73.55%
JP:2689JP:268953NeutralJPY 18.91B10.94―4.44%2.20%-31.67%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:9265JP:926550NeutralJPY 8.77B15.59―3.11%-0.41%2.32%
JP:7061JP:706149NeutralJPY 3.03B-28.40――6.75%-119.69%

* Healthcare Sector Average

Performance Comparison

-50%0%50%JP:9265JP:2425JP:2689JP:3417JP:6062JP:7061Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:9265 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:9265YAMASHITA HEALTH CARE HOLDINGS, INC.3435.00253.117.95%
JP:2425Care Service Co., Ltd.658.00-115.78-14.96%
JP:2689OLBA HEALTHCARE HOLDINGS, Inc.1803.00-142.36-7.32%
JP:3417Ohki Health Care Holdings, Inc.945.00-444.46-31.99%
JP:6062Charm Care Corporation1964.00727.3658.82%
JP:7061Japan Hospice Holdings Inc.357.00-924.94-72.15%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026